Ruth Röck

Ruth Röck

Auto-generated profile, based on publicly available information

Ruth Röck

Institute of Anatomy, University of Zurich, Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
RRRuth Röck
Ruth Röck
JMJohanna E. Mayrhofer
Johanna E. Mayrhofer
OTOmar Torres-Quesada
Omar Torres-Quesada
FEFlorian Enzler
Florian Enzler
ARAndrea Raffeiner
Andrea Raffeiner
ESEduard Stefan
Eduard Stefan
Patient mutation–specific BRAF inhibitors alter full-length kinase conformations and promote interactions with GTP-loaded RAS.

23 November 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
JMJohanna E. Mayrhofer
Johanna E. Mayrhofer
FEFlorian Enzler
Florian Enzler
AFAndreas Feichtner
Andreas Feichtner
RRRuth Röck
Ruth Röck
JFJakob Fleischmann
Jakob Fleischmann
ESEduard Stefan
Eduard Stefan
Significance: The pharmaceutical targeting of mutated BRAF has shown promising clinical outcomes in patients with melanoma. However, more than 300 reported BRAF patient mutations and the occurrence of a kinase-drug resistance mechanism hamper patient-oriented therapies. We have developed an extendable and cell-based kinase conformation reporter platform (KinCon) to predict and compare the effect of kinase drugs. We systematically evaluated drug efficacies by assessing KinCon reporter dynamics in response to different drugs and patient mutations. Our findings suggest that FDA-approved melanoma inhibitors may have the potential to block non-V600E–mutated BRAF activities also in non–small-cell lung cancers (NSCLC). We assume that widespread analyses of KinCon:drug interactions may assist in the future in identifying patient mutation–specific and thus more effective kinase inhibitors.

12 August 2025 in Nature Biotechnology
Verified
Journal Article
Open access
TNThomas Naert
Thomas Naert
TYTaiyo Yamamoto
Taiyo Yamamoto
SHShuting Han
Shuting Han
RRRuth Röck
Ruth Röck
MHMelanie Horn
Melanie Horn
SLSoeren S. Lienkamp
Soeren S. Lienkamp
Precise CRISPR-based DNA integration and editing remain challenging, largely because of insufficient control of the repair process. We find that repair at the genome–cargo interface is predictable by deep learning models and adheres to sequence-context-specific rules. On the basis of in silico predictions, we devised a strategy of base-pair tandem repeat repair arms matching microhomologies at double-strand breaks. These repeat homology arms promote frame-retentive cassette integration and reduce deletions both at the target site and within the transgene. We demonstrate precise integrations at 32 loci in HEK293T cells. Germline-transmissible transgene integration and endogenous protein tagging in Xenopus and adult mouse brains demonstrated precise integration during early embryonic cleavage and in nondividing, differentiated cells. Optimized repair arms also facilitated small edits for scarless single-nucleotide or double-nucleotide changes using oligonucleotide templates in vitro and in vivo. We provide the design tool Pythia to facilitate precise genomic integration and editing for experimental and therapeutic purposes for a wide range of target cell types and applications.

1 July 2022 in Physiology
Verified
Journal Article
Closed access
PDF file
RRRuth Röck
Ruth Röck
LRLudovica Rizzo
Ludovica Rizzo
SLSoeren S. Lienkamp
Soeren S. Lienkamp
The kidney is a complex organ, and how it forms is a fascinating process. New technologies, such as single-cell transcriptomics, and enhanced imaging modalities are offering new approaches to understand the complex and intertwined processes during embryonic kidney development.

1 May 2020 in Molecular Cancer Research
Verified
Journal Article
Closed access
RRRuth Röck
Ruth Röck
JMJohanna Mayrhofer
Johanna Mayrhofer
OTOmar Torres-Quesada
Omar Torres-Quesada
FEFlorian Enzler
Florian Enzler
Jakob TroppmairJakob Troppmair
Jakob Troppmair
ESEduard Stefan
Eduard Stefan
Live-cell recordings of protein conformations and interactions yield novel mechanistic insights into physiologic and pathologic protein functions. We have developed an adaptable and genetically encoded bioluminescence-based biosensor platform to precisely measure signaling dynamics of full-length RAS GTPases and RAF kinases upon physiologic pathway activation, post-translational modifications, mutagenesis, and drug binding. We have recorded the impact of both patient mutations and bioactive small-molecule binding on kinase conformations and binary interactions of GTP-loaded H, N, KRAS with kinases such as RAF. Systematic profiling of αC-helix-OUT BRAF inhibitors (BRAFi) vemurafenib, dabrafenib, encorafenib, and PLX8394 using the BRAF reporter reporter platform (displaying 10 different patient mutations) revealed differences in drug specificities and efficacies. Unexpectedly, the αC-helix-OUT BRAFi engagement with the catalytic pocket of mutated BRAF stabilized an inactive and intermediate full-length kinase conformation, which provoked the enhancement of binary RAS:RAF interactions. We showed that the interference with RAS interactions and nanoclustering has the potential to antagonize the sequential formation of drug-induced tetrameric RAS:RAF complexes. Recently, we have bioengineered a reporter toolbox for direct in vivo recordings of RAS activity conformations. First, we demonstrated that the wild-type RAS reporter—expressed at levels far below endogenous RAS proteins—responds to physiologic pathway activation. Second, we showed that hot-spot RAS mutations display a similar effect on the intramolecular dynamics. The systematic implementation, combination, and advancement of the GTPase and kinase reporter platform have the potential to be used to identify novel means for regulating or perturbing RAS-RAF-ERK signaling in vivo. Citation Format: Ruth Röck, Johanna Mayrhofer, Omar Torres-Quesada, Florian Enzler, Jakob Troppmair, Eduard Stefan. Surveillance of RAS-RAF dynamics in vivo: Tracking activity conformations and drug-induced interactions [abstract]. In: Proceedings of the AACR Special Conference on Targeting RAS-Driven Cancers; 2018 Dec 9-12; San Diego, CA. Philadelphia (PA): AACR; Mol Cancer Res 2020;18(5_Suppl):Abstract nr B45.